EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Double the Double: Revisiting BCL11B 's Multimerization

Anne Susemihl, Norman Geist iD, Piotr Grabarczyk, Christian A Schmidt, Mihaela Delcea, Lukas Schulig iD

Proteins: Structure, Function, and Bioinformatics · 2025-07 · 93 (7) · 1205-1211

DOI: 10.1002/prot.26811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proteins: Structure, Function, and Bioinformatics, online erschienen am 20.02.2025. Verfasst von Anne Susemihl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, Greifswald, Germany. Hauptthemen laut MEDLINE: Protein Multimerization, Repressor Proteins, Tumor Suppressor Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcription factor B Cell Lymphoma/Leukemia 11B (BCL11B) exerts a bi‐directional function in cancer, with its role as an emerging therapeutic target in cancer treatment being particularly intriguing. BCL11B knockouts in cultured T cells revealed the acquisition of properties characteristic of natural killer cells, hinting at its importance in innate versus adaptive immune regulation. Our previous studies using Förster Resonance Energy Transfer‐assisted Fluorescence‐Activated Cell Sorting and Hybrid Solvent Replica‐Exchange Simulations indicated that BCL11B forms dimers, with this being a prerequisite for its activity. However, size exclusion chromatography and crosslinking experiments have challenged this view, suggesting that BCL11B forms tetramers instead. An atypical CCHC zinc finger motif within the N ‐terminal region of the protein mediates multimerization and a novel 3D structure is presented based on extensive replica‐exchange simulations in strong agreement with experimental data. The physiological relevance of multimer formation of this zinc finger protein has been demonstrated previously. Therefore, understanding the nature of BCL11B's multimerization could potentially enhance our ability to target this protein effectively, hopefully paving the way for novel BCL11B‐targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein MultimerizationRepressor ProteinsTumor Suppressor ProteinsHumansZinc FingersModels, MolecularMolecular Dynamics SimulationProtein BindingAnimals

Stichwörter der Autor:innen

BCL11BCCHC zinc fingerTIGER2hPEcrosslinkingprotein–protein dockingprotein–protein interactionsreplica‐exchange molecular dynamicssize exclusion chromatographytetramers

Substanzen

BCL11B protein, humanRepressor ProteinsTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, Greifswald, Germany.
  • Comprehensive Cancer Center Mecklenburg-Vorpommern, University of Greifswald, Greifswald, Germany.
  • Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.

ORCID-Profile: Norman Geist, Lukas Schulig

Zitieren

APA

Susemihl, A., Geist, N., Grabarczyk, P., Schmidt, C. A., Delcea, M., & Schulig, L. (2025). Double the Double: Revisiting BCL11B 's Multimerization. Proteins: Structure, Function, and Bioinformatics, 93(7), 1205-1211. https://doi.org/10.1002/prot.26811

Vancouver

Susemihl A, Geist N, Grabarczyk P, Schmidt CA, Delcea M, Schulig L. Double the Double: Revisiting BCL11B 's Multimerization. Proteins: Structure, Function, and Bioinformatics. 2025;93(7):1205-1211. doi:10.1002/prot.26811

BibTeX
@article{Susemihl2025,
  author = {Susemihl, Anne and Geist, Norman and Grabarczyk, Piotr and Schmidt, Christian A and Delcea, Mihaela and Schulig, Lukas},
  title = {Double the Double: Revisiting BCL11B 's Multimerization},
  journal = {Proteins: Structure, Function, and Bioinformatics},
  year = {2025},
  volume = {93},
  number = {7},
  pages = {1205--1211},
  doi = {10.1002/prot.26811}
}
Kostenlos starten →